Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Frequent plateletpheresis does not clinically significantly decrease platelet counts in donors.

Louis Katz1, Kim Palmer, Emily McDonnell

  • 1Mississippi Valley Regional Blood Center, Davenport, Iowa, USA. lkatz@mvrbc.com

Transfusion
|August 30, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Defining the Human Nucleus Pulposus Microenvironment and Its Impact on Cell Matrix Synthesis and Metabolic Activity.

JOR spine·2026
Same author

Influence of the Intervertebral Disc Microenvironment on Matrix Synthesis and Metabolism in Goat Nucleus Pulposus Cells.

JOR spine·2026
Same author

Feasibility of a Yoga Intervention for Children and Adolescents Undergoing Hematopoietic Cell Transplant.

Physical & occupational therapy in pediatrics·2025
Same author

Steps Forward to a Fair and Inclusive Blood Supply.

Clinics in laboratory medicine·2024
Same author

Establishment of human post-vaccination SARS-CoV-2 standard reference sera.

Journal of immunological methods·2024
Same author

Prospective 1-year results of atrial fibrillation ablation using the pentaspline pulsed field ablation catheter: The initial French experience.

Archives of cardiovascular diseases·2024
Same journal

Investigation of the preanalytical stability of blood donor samples.

Transfusion·2026
Same journal

The need for dried plasma-Still a national issue: Where are we and recommendations.

Transfusion·2026
Same journal

Spray dried plasma manufactured from apheresis and whole blood derived plasma.

Transfusion·2026
Same journal

Identification of a novel ABO*A1.01 allele with c.562C>T (p.Arg188Cys) mutation associated with A<sub>el</sub> phenotype in a Chinese individual.

Transfusion·2026
Same journal

AABB survey on directed blood donation practices.

Transfusion·2026
Same journal

Cost analysis considerations for red blood cell matching to mitigate alloimmunization in patients with sickle cell disease.

Transfusion·2026
See all related articles

Proposed FDA restrictions on platelet (PLT) collections are unnecessary. Frequent PLT donors show no clinically significant PLT count declines, and protein levels remain stable, ensuring apheresis PLT supply.

Area of Science:

  • Hematology
  • Transfusion Medicine

Background:

  • US FDA proposed limiting automated platelet (PLT) collections to 24 components annually.
  • Rationale included concerns about frequent PLT collection impacting donor PLT counts.
  • Proposed restrictions also included minimal interdonation intervals.

Purpose of the Study:

  • To assess the impact of proposed FDA restrictions on PLT collections.
  • To evaluate the effect of collection frequency, number of products, and interdonation interval on donor PLT counts.
  • To compare protein and albumin levels in frequent PLT donors versus control donors.

Main Methods:

  • Analysis of plateletpheresis records with predonation PLT counts.
  • Review of donor PLT counts in relation to collection frequency and interdonation intervals.

Related Experiment Videos

  • Comparison of total protein and albumin levels between frequent PLT donors and whole-blood donors.

    • Main Results:

    • A 24-component limit would necessitate replacing ~20% of donors to maintain supply.
    • No clinically significant decrease in donor PLT counts was observed up to 24 collections/year.
    • Frequent donors were not deferred for low PLT counts; protein levels were comparable to controls.

    Conclusions:

    • Proposed FDA restrictions on PLT collections are not needed to prevent thrombocytopenia in frequent donors.
    • Restrictions would negatively impact the apheresis PLT supply.
    • High-frequency PLT donors maintain adequate protein levels.